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Forkhead box P3 positive (Foxp3+) regulatory T
(Treg) cells suppress immune responses and regu-
late peripheral tolerance. Here we show that the
atypical inhibitor of NFkB (IkB) IkBNS drives Foxp3
expression via association with the promoter and
the conserved noncoding sequence 3 (CNS3) of the
Foxp3 locus. Consequently, IkBNS deficiency leads
to a substantial reduction of Foxp3+ Treg cells in vivo
and impaired Foxp3 induction upon transforming
growth factor-b (TGF-b) treatment in vitro. Moreover,
fewer Foxp3+ Treg cells developed from IkBNS-defi-
cient CD25CD4+ T cells adoptively transferred into
immunodeficient recipients. Importantly, IkBNS was
required for the transition of immature GITR+CD25+
Foxp3 thymic Treg cell precursors into Foxp3+
cells. In contrast to mice lacking c-Rel or Carma1,
IkBNS-deficient mice do not show reduced Treg
precursor cells. Our results demonstrate that IkBNS
critically regulates Treg cell development in the
thymus and during gut inflammation, indicating that
strategies targeting IkBNS could modulate the Treg
cell compartment.
INTRODUCTION
Regulatory T (Treg) cells represent an essential T cell subset
governing the maintenance of peripheral tolerance and immune
homeostasis. Their capacity to suppress the activity of effector
immune cells enables them to regulate the duration and intensity
of the immune response and to prevent autoimmunity (Saka-
guchi et al., 1995, 2007). Loss of functional Treg cells leads to
a fatal autoimmune disease, termed immune dysregulation,
polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) in998 Immunity 37, 998–1008, December 14, 2012 ª2012 Elsevier Inc.humans, or the homologous murine phenotype called scurfy.
Both are caused by mutations in the transcription factor
forkhead box P3 (Foxp3), which controls the development and
phenotypic maintenance of Treg cells (Bennett et al., 2001;
Brunkow et al., 2001; Hori et al., 2003).
The pool of Foxp3+ Treg cells consists of induced (iTreg) and
natural (nTreg) cells, the former being generated in peripheral
lymphoid tissues by the conversion of naive CD4+Foxp3
T cells into mature CD4+Foxp3+ cells. This process takes place
in tissues such as the gut, which need high immune tolerance.
This conversion requires T cell receptor (TCR) triggering as
well as gc cytokine stimulation in order to enhance Foxp3
expression, Treg cell survival and expansion through the signal
transducer and activator of transcription 5 (STAT5) (Burchill
et al., 2007). Additionally, transforming growth factor-b (TGF-b)
contributes to Treg cell maintenance and homeostasis via
Smad3 signaling, as TGF-b1-deficient mice display reduced
peripheral Treg cell numbers (Marie et al., 2005). In vitro, CD4+
Foxp3 T cells are converted into Foxp3+ cells by activation in
the presence of TGF-b (Chen et al., 2003). However, in contrast
to Treg cells developed in vivo, demethylation of CpG siteswithin
the conserved noncoding sequence 2 (CNS2) of the Foxp3 locus,
also known as Treg-specific demethylation region (TSDR), does
not occur (Floess et al., 2007; Zheng et al., 2010). As a result, the
in vitro-induced Foxp3 expression is less stable (Polansky et al.,
2008).
The essential signals for thymic nTreg cell development are
TCR engagement, CD28 costimulation, and gc cytokine signals
(Vang et al., 2008). Interestingly, comparison of TCR specificities
between Foxp3 and Foxp3+ T cells revealed that Treg cells
express autoreactive TCRs (Apostolou et al., 2002; Hsieh et al.,
2004; Jordan et al., 2001; Liston and Rudensky, 2007). These
observations suggest that developing thymic nTreg cells
escape negative selection. The currently most accepted ‘‘two-
step model’’ of nTreg cell generation assumes that TCR-
mediated signals in autoreactive CD4+ cells induce expression
of the interleukin-2 (IL-2) receptor a chain (CD25) and the
glucocorticoid-induced-TNF-receptor (GITR), leading to the
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induced in CD4+CD25+GITR+Foxp3 precursors by gc cytokines
IL-2 and IL-15 (Burchill et al., 2008; Lio and Hsieh, 2008).
It was previously demonstrated that nTreg cell and iTreg cell
development depend on the transcription factor NFkB (Barnes
et al., 2009; Grigoriadis et al., 2011; Long et al., 2009; Ruan
et al., 2009). Due to its impact on proliferation, cell death, and
lymphocyte activation, NFkB is one of the most important
eukaryotic transcription factor networks (Baldwin, 1996; Weil
and Israe¨l, 2006). Functional NFkB transcription factors are
dimers formed by two members of the Rel-protein family. TCR
stimulation involves p65, c-Rel and p50 (Bonizzi and Karin,
2004). The central event in NFkB signaling is the activation of
the IkB kinase (IKK) complex (Hayden and Ghosh, 2012). This
trimeric protein complex consists of two catalytic subunits,
IKKa and IKKb, and the scaffold protein IKKg (Hayden and
Ghosh, 2012). The IKKb subunit of active IKK-complexes phos-
phorylates the cellular inhibitors of NFkB (termed IkBs), which
sequester NFkB in the cytoplasm by masking their nuclear local-
ization signals. Upon phosphorylation, classical IkBs are polyu-
biquitinated and degraded. Eventually, NFkB translocates into
the nucleus and binds to kB-sites on the DNA (Perkins and
Gilmore, 2006). Classical IkBs are distinguished from the atypical
IkB proteins of the BCL-3 subfamily, such as BCL-3, IkBz
(encoded by the Nfkbiz gene), and IkBNS (encoded by the Nfkbid
gene) (Hayden and Ghosh, 2012). The latter proteins are not
degraded after NFkB activation but are highly induced and,
notably, act as transcriptional modulators with inductive and
repressive capacities by binding to NFkB transcription factors
in the nucleus (Ghosh and Hayden, 2008; Mankan et al., 2009).
Essential for nTreg cell lineage commitment is a protein kinase
C-Q-activated complex formed by Carma1 (encoded by the
Card11 gene), BCL-10, and MALT1 (CBM) (Barnes et al., 2009;
Thome, 2004). Notably, Card11-deficient mice lack thymic
CD25+GITR+Foxp3 Treg precursor cells, leading to a massive
reduction in mature Treg cell numbers (Molinero et al., 2009)
Because the CBM complex is proximal to the TCR, constitutively
active IKKb rescues the induction of Foxp3 in Card11-deficient
Treg precursor cells (Long et al., 2009). Regarding distal NFkB
signaling, it was shown that c-Rel controls Treg cell precursor
generation and drives Foxp3 expression by binding to the
promoter, CNS2, and CNS3 within the Foxp3 locus (Hori, 2010;
Hsieh, 2009; Isomura et al., 2009; Ruan et al., 2009; Zheng
et al., 2010). However, whether or not atypical IkB proteins
contribute to Treg cell development has not been analyzed yet.
The function of the BCL-3 subfamily protein IkBNS is almost
completely unknown. It was first identified in autoreactive
T cells of a mouse model for peptide-induced negative selection
(Fiorini et al., 2002). However, neither distribution of CD4-
and CD8-positive cells in the thymus and secondary lymphoid
organs nor Vb usage are affected by Nfkbid deficiency, but
CD8+ T cells of Nfkbid-deficient mice show reduced IL-2 and
IFN-g production after TCR triggering (Touma et al., 2007). We
found that Nfkbid-deficient mice show a 50% reduction of
mature Treg cells. Unlike Card11-deficient mice, which display
virtually no GITR+CD25+Foxp3 Treg precursor cells, Nfkbid
deficiency leads to an increase of these precursor cells due to
impaired transition into Foxp3+ Treg cells. Moreover, IkBNS is
transiently expressed during thymic nTreg cell developmentImand drives Foxp3 induction by binding to the promoter and
CNS3 via p50 and c-Rel. Taken together, our data identify
IkBNS as a crucial regulator of Foxp3 induction during Treg cell
development and Treg cell generation under chronic inflamma-
tory conditions.
RESULTS
IkBNS Intrinsically Controls Treg Cell Numbers
A minority of autoreactive T cells is protected from negative
selection, commences Foxp3 expression, and develops into
nTreg cells (Lio and Hsieh, 2008; Liston and Rudensky, 2007).
Consequently, the majority of Foxp3+ Treg cells express TCRs
recognizing self-peptides (Apostolou et al., 2002; Hsieh et al.,
2004; Jordan et al., 2001; Liston and Rudensky, 2007). Although
IkBNS was first identified in autoreactive T cells (Fiorini et al.,
2002), negative selection is not altered in Nfkbid-deficient mice
as demonstrated by the normal percentages and development
of conventional T cells (see Figure S1A and S1B available online)
(Kuwata et al., 2006; Touma et al., 2007). To uncover whether
IkBNS is crucial for directing autoreactive T cells to the Treg
cell lineage, we determined Treg cell frequencies by intracellular
staining of Foxp3 in Nfkbid-deficient and wild-type (WT) mice.
Nfkbid-deficient mice displayed a reduction of Treg cells in
thymus, spleen, mesenteric, and peripheral lymph nodes (Fig-
ure 1A and 1B). In line with reduced Treg cell frequencies, their
total number was diminished in Nfkbid-deficient mice as well
(Figure 1B). Numbers and frequencies of the total CD4+ T cell
compartment were comparable between Nfkbid-deficient and
WTmice (Figure 1C). Moreover, frequencies of Foxp3+ Treg cells
in WT, heterozygous, and Nfkbid-deficient littermate mice were
significantly different in thymus, mesenteric, and peripheral
lymph nodes, indicating that IkBNS modulates the generation
of Treg cells in a dose-dependent manner (Figure S1C) without
affecting the total CD4+ T cell compartment (Figure S1D). In addi-
tion, the activation status of conventional T cells assessed by
CD62L and CD44 expression was similar in Nfkbid-deficient
mice (Figure S1E and S1F).
To determine whether IkBNS affects Treg cell generation by
extrinsic factors or via an intrinsic mechanism, we generated
mixed bone marrow chimeric mice. The composition of the
CD4+Foxp3+ Treg cell compartment by Nfkbid+/+Thy1.1 and
Nfkbid/Thy1.2 cells was analyzed by flow cytometry 8 weeks
after bone marrow transfer (Figure 1D). Nfkbid/Thy1.2 Treg
cells were virtually not detectable, whereas the CD4+Nfkbid+/+
Thy1.1 compartment exhibited normal Treg cell frequencies of
about 9% (Figure 1E). Because the presence of WT T cells could
not overcome Nfkbid deficiency in mixed bone marrow chimeric
mice, IkBNS intrinsically regulates Treg cell development.
IkBNS Deficiency Neither Enhances Treg Cell Apoptosis
nor Reduces Treg Cell Proliferation
NFkB is known to support proliferation and survival (Hayden and
Ghosh, 2012). To determine whether the reduced amount of
Treg cells in Nfkbid-deficient mice is caused by impaired prolif-
eration or enhanced apoptosis, Nfkbid-deficient mice were
crossed with Foxp3DTR-eGFP reporter mice, allowing analysis of
nonfixed Treg cells. Similar to nonreporter mice, Treg cell
frequencies were reduced inNfkbid/Foxp3DTR-eGFP comparedmunity 37, 998–1008, December 14, 2012 ª2012 Elsevier Inc. 999
Figure 1. IkBNS
–/– Mice Display Reduced Treg Cell Frequencies and Numbers
(A) Flow cytometric analysis of Treg cell frequencies in the spleen, thymus, and mesenteric (mLN) and peripheral lymph nodes (pLN) of WT (Nfkbid+/+) and
IkBNS-deficient (Nfkbid
/) mice assessed by intracellular Foxp3 staining. Representative pseudocolor dot plots of Foxp3+ Treg cells within CD4+ cells in 8-week-
old mice are shown. Numbers indicate the percentages of gated CD4+Foxp3+ Treg cells.
(B) Percentages and absolute numbers of Foxp3+ Treg cells within CD4+ cells in spleen, thymus, and peripheral and mesenteric lymph nodes of WT (Nfkbid+/+)
and IkBNS-deficient (Nfkbid
/) mice (n = 9 each) are shown.
(C) Flow cytometric analysis of the CD4+ T cell compartment. Percentages and absolute numbers of CD4 cells in spleen, thymus, and peripheral and mesenteric
lymph nodes of Nfkbid+/+ and Nfkbid/ mice (n = 9 each) are shown.
(D) Mixed bone marrow chimeric mice were analyzed 8 weeks after transfer ofNfkbid+/+Thy1.1 andNfkbid/Thy1.2 bone marrow cells into sublethally irradiated
WT recipient mice. Representative pseudocolor dot plots of splenic CD4+Thy1.1 and CD4+Thy1.2 cells and of CD4+Foxp3+ cells pregated toNfkbid+/+Thy1.1+ or
Nfkbid/Thy1.2+ cells are shown.
(E) Percentages (left panel) and absolute numbers (right panel) of splenic CD4+Foxp3+ Treg cells of Nfkbid+/+ and Nfkbid/ origin in bone marrow chimeras. For
(B), (C), and (E), each symbol indicates an individual mouse. Horizontal lines represent the mean; error bars represent SEM. Statistical analyses were performed
by two-tailed Mann-Whitney tests; a < 0.05; n.s., not significant.
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apoptosis, analyzed by the frequencies of early apoptotic
(AnnexinV+7AAD) and late apoptotic (AnnexinV+7AAD+)
CD4+GFP+ Treg cells were comparable between WT and
Nfkbid/mice (Figures 2A and 2B; Figure S2B). To corroborate
this data, we also measured Treg cell viability by staining with
tetramethylrhodamine ethyl ester (TMRE). Cells that have lost
mitochondrial membrane integrity during early apoptosis are
TMRE low. In agreement with AnnexinV/7AAD analyses,
no significant difference between Treg cells of Nfkbid+/+
Foxp3DTReGFP and Nfkbid/Foxp3DTReGFP mice was detectable
(Figure 2C). Also, cell death of CD4+Foxp3 conventional T cells
was unaffected by Nfkbid deficiency (Figures 2A–2C).
Previous studies reported reduced proliferation of Nfkbid-
deficient conventional T cells upon stimulation via CD3 and
CD28 in vitro (Touma et al., 2007). Thus, the possibility of
defective Treg cell proliferation was investigated by analyzing
the expression of the Ki67 proliferation marker, which is downre-1000 Immunity 37, 998–1008, December 14, 2012 ª2012 Elsevier Incgulated in the G0-arrest of the cell cycle. Remarkably, Foxp3+
Treg cells of the thymus and peripheral lymphoid organs from
Nfkbid-deficient mice displayed increased amounts of Ki67-
positive cells (Figures 2D and 2E). To confirm this data, we fed
mice orally with BrdU, which is incorporated into the DNA during
the S phase. Corresponding to the Ki67 data, peripheral Nfkbid-
deficient Treg cells displayed increased BrdU incorporation
(Figures S2C and S2D). Proliferation of conventional T cells
was unaffected in vivo (Figures 2D and 2E; Figures S2C and
S2D). Compendious, Nfkbid-deficient mice displayed neither
increased basal apoptosis nor decreased proliferation of Treg
cells but a certain increase in proliferation.
IkBNS-Deficient Naive T Cells Display Reduced Foxp3
Induction upon TGF-b Treatment or Adoptive Transfer
into Rag1–/– Mice
As steady state generation of Treg cells was impaired upon
Nfkbid deficiency, we analyzed whether IkBNS affects iTreg cell.
Figure 2. IkBNS-Deficient Treg Cells Undergo Enhanced Proliferation but Display Normal Apoptosis
(A) Representative zebra plots of the AnnexinV/7AAD distribution of thymic GFP+ Treg and GFP Tcon cells from Nfkbid+/+Foxp3DTR-eGFP and
Nfkbid/Foxp3DTR-eGFP mice.
(B) Statistical summary of apoptosis among GFP+ Treg cells and GFP Tcon cells from the thymus of Nfkbid+/+Foxp3DTR-eGFP (filled bars) and
Nfkbid/Foxp3DTR-eGFP (open bars) mice is shown (n = 6 for each). AxV/7AAD cells are living cells, AxV+/7AAD are early apoptotic cells, and AxV+/7AAD+ are
late apoptotic cells.
(C) CD4+Foxp3+ Treg cells and CD4+Foxp3 Tcon cells from spleen, thymus, and peripheral and mesenteric lymph nodes from Nfkbid+/+Foxp3DTR-eGFP and
Nfkbid/Foxp3DTR-eGFP mice (n = 6 for each) were stained with TMRE to assess mitochondrial membrane potential. Statistical summary of the percentages of
TMRE low (early apoptotic) cells is shown.
(D) Flow cytometric analysis of Ki67 expression in pregated CD4+Foxp3+ Treg cells and CD4+Foxp3 Tcon cells from thymi, spleens, and peripheral and
mesenteric lymph nodes. Representative Ki67-histogram overlays of cells from WT, heterozygous, and Nfkbid-deficient mice are shown.
(E) Statistical analysis of Ki67-positive cells among pregatedCD4+Foxp3+ Treg cells and CD4+Foxp3 Tcon cells ofWT (Nfkbid+/+; n = 3), heterozygous (Nfkbid-/+;
n = 4), and IkBNS-deficient (Nfkbid
/; n = 5) mice are shown. For (B), (C), and (E) error bars display SEM. Statistical analyses were performed by two-tailed Mann-
Whitney tests; a < 0.05. n.s., not significant.
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T cells stimulated in vitro with low dose TGF-b in the presence
of IL-2 commenced less Foxp3 expression compared to WT
cells (Figure 3A). In the latter, IkBNS was induced during the
early stages of TGF-b treatment (Figure S3A). High TGF-b
concentrations, however, could overcome Nfkbid deficiency
(Figure 3A). Staining of Ki67 revealed that the reduced amount
of Foxp3 expressing cells was not the result of a proliferation
defect (Figure 3B). Because in vitro differentiation implied
impaired iTreg cell development, naive CD25CD4+ T cells
from WT or Nfkbid-deficient mice were adoptively transferred
into Rag1/ mice and Treg cell development in the gut was
monitored. Flow cytometric analysis of lamina propria mono-
nuclear cells (LPMC) revealed that CD4+Foxp3+ Treg cells
barely developed fromNfkbid-deficient T cells, whereas approx-
imately 5% of Treg cells originated from WT cells (Figure 3C).
Accordingly, reduced frequencies and absolute numbers of
Foxp+ Treg cells were found in histological analyses (Figure 3D).
In contrast, frequencies of total CD4+ T cells in the LPMCs
(Figure S3B) and IFN-g producing cells were comparable
between both groups (Figure 3E). However, Rag1/ mice that
had received Nfkbid-deficient T cells showed signs of severeImmcolitis compared to control recipients, as revealed by stronger
leukocyte infiltration of the large intestine (Figure 3F). Histopa-
thology revealed severe inflammation in recipients of Nfkbid-
deficient T cell, compared to recipients of WT T cells (Figure 3G).
Accordingly, weight loss was exacerbated upon transfer of
Nfkbid-deficient T cells (Figure 3H; Figure S3C), associated
with increased colon shortening (Figure S3D) and severe
diarrhea (Figure S3E). There was no statistical difference in
the IL-6 release between both groups, but IFN-g amounts
in colon sections of Nfkbid-deficient T cell recipients were
elevated, reflecting enhanced inflammation (Figure 3I). These
experiments illustrate that IkBNS was required for Foxp3 induc-
tion upon TGF-b treatment and in adoptively transferred naive
T cells.
IkBNS Does Not Modulate the Suppressor Function
of Mature Treg Cells
So far, our data indicated impaired induction of Foxp3 in Nfkbid-
deficient mice. To elucidate whether IkBNS is crucial for the
function and maintenance of mature Treg cells, we examined
the expression of Treg cell signature proteins CD25 (IL-2Ra),
GITR, Foxp3, CD122 (IL-2Rb), and CTLA-4 in Treg cells fromunity 37, 998–1008, December 14, 2012 ª2012 Elsevier Inc. 1001
Figure 3. IkBNS Deficiency Impairs TGF-b-Mediated Induction of Foxp3 and iTreg Cell Development from Adoptively Transferred Tcon Cells
(A) Purified naive CD4+CD62L+CD25 T cells were treated with the indicated TGF-b concentrations in the presence of 10 ng/ml of IL-2. Statistical summary of
Foxp3+ cells analyzed by flow cytometry at days 1, 3, and 5 is shown. Filled bars represent WT; open bars indicate Nfkbid-deficient cells.
(B) Flow cytometry analyses of Ki67 expressing cells pregated to in vitro induced Foxp3+ Treg cells and Foxp3 Tcon cells (n = 6). Red indicates WT; blue
indicates Nfkbid-deficient cells. Grey represents Ki67 histogram at day 1.
(C) Treg cell induction in Rag1-deficient mice. The development of Treg cells from transferred Nfkbid+/+ or Nfkbid/ T cells, was analyzed by flow cytometry.
Representative pseudocolor dot-plots of CD4+Foxp3+ Treg cells from the lamina propria pregated on CD4+ T cells and statistical summary are shown.
(D) Frequencies and numbers of Treg cells of Nfkbid+/+ (n = 9) or Nfkbid/ (n = 5) origin in colon sections analyzed by immunohistology. Numbers of cells per 10
high power fields (HPF) are shown.
(E) Representative pseudocolor dot-plots of CD4+IFN-g+ T cells pregated on CD4+ T cells in the lamina propria from transferred Nfkbid+/+ and Nfkbid/ T cells
and statistical summary are shown. Numbers indicate the percentages of gated CD4+IFN-g+ T cells.
(F) Representative hematoxylin and eosin stained colon sections fromRag1-deficient mice injectedwith PBS,WT (Nfkbid+/+) T cells, or IkBNS-deficient (Nfkbid
/)
T cells are shown. Scale bar represents 100 mm.
(G) Histopathology scoring from Rag1-deficient mice injected with PBS (n = 4),Nfkbid+/+ (n = 8), orNfkbid/ (n = 5) T cells is shown. Diagram height indicates the
mean; error bars represent SEM.
(H) Normalized weights of Rag1-deficient mice, injected with PBS (n = 4), Nfkbid+/+ (n = 8), or Nfkbid/ (n = 5) T cells are shown. Each point indicates the mean;
error bars represent SEM.
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Figure 4. IkBNS Is Dispensable for the
Phenotypic Maintenance of Regulatory T
Cells
(A) Flow cytometric analysis of the expression of
CD25, CD122, GITR, intracellular CTLA-4, and
Foxp3. Representative histogram overlays of the
indicated proteins of CD4+Foxp3 Tcon cells and
CD4+Foxp3+ Treg cells from the spleens of WT
(Nfkbid+/+) and IkBNS-deficient (Nfkbid
/) mice
are shown. Results are representative for three
independent experiments.
(B) CD4+CD25+ Treg cells and CD4+CD25
conventional T cells (Tcon) were sorted by flow
cytometry to determine the CNS2/TSDR methyla-
tion status. Representative pseudocolor dot-plots
of sorted cells from Nfkbid+/+ and Nfkbid/ male
mice are shown. For each plot, the upper numbers
indicate percentages of CD4+CD25+ Treg cells,
and lower numbers indicate the percentages of
CD4+CD25 Tcon cells. Data are representative of
WT (n = 4) and Nfkbid-deficient (n = 8) cells.
(C) Representative CNS2/TSDR methylation
patterns of purified CD4+CD25+ Treg cells and
CD4+CD25 conventional T cells isolated as in (B).
Amplicons are vertically arranged, each repre-
senting a single CpG-motif. Color code indicates
the percentage of CNS2/TSDR methylation in the
purified populations.
(D) The suppressive capacity of IkBNS-deficient
(Nfkbid/) Treg cells compared to WT (Nfkbid+/+)
Treg cells was analyzed in vitro. Representative
histogram overlays of CFSE-labeled WT conven-
tional T cells (Tcon) cocultured for 3 days with Treg
cells of Nfkbid+/+ and Nfkbid/ mice at the indi-
cated ratios are shown.
(E) Percentage of proliferating Tcon cells during
in vitro suppression assay as in (D) is shown. Data
are representative for three independent triplicate
measurements. Each symbol represents the
mean; error bars represent the SD.
(F) Expression of IkBNS in purified CD4
+CD25+ Treg cells and CD4+CD25 Tcon cells, stimulated with 10 mg/ml anti-CD3, 5 mg/ml anti-CD28, and 10 ng/ml
murine IL-2, analyzed by qPCR (n = 4). Error bars display SEM. Statistical analyses were performed by two-tailed Mann-Whitney tests; a < 0.05; n.s., not
significant.
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were comparable in CD4+Foxp3+ cells obtained from thymus,
spleen, peripheral, and mesenteric lymph nodes of Nfkbid-defi-
cient and WT mice (Figure 4A; Figure S4A).
To further characterize mature Treg cells, we analyzed the
epigenetic regulation of Foxp3 by determining the methylation
status of CNS2 in the Foxp3 locus. CpG motifs in the CNS2
are fully methylated in conventional T cells and demethylated
in Treg cells, a requirement for stable Foxp3 expression (Floess
et al., 2007; Polansky et al., 2008). CD4+CD25 conventional
T cells and CD4+CD25+ Treg cells were purified from Nfkbid-
deficient and WT mice (Figure 4B), purity of the isolated popula-
tions was determined by Foxp3 staining (Figure S4B), and the
CNS2 methylation status was analyzed as previously reported
(Floess et al., 2007; Polansky et al., 2008). Both genotypes dis-(I) Release of proinflammatory cytokines was determined via bead-based assays
Nfkbid+/+ (n = 7) or Nfkbid/ (n = 5) T cells are shown. Diagram height indicates th
Foxp3+ Treg cells. For (A), (G), and (I), horizontal lines indicate themean. For (C), (D
the mean; error bars represent SEM. Statistical analyses were performed by two
Immplayed full CNS2 methylation in CD4+CD25 T cells and similar
demethylation of CNS2 in CD4+CD25+ Treg cells (Figure 4C; Fig-
ure S4C). Furthermore, the suppressive capacity of mature
CD25+ Treg cells in vitro isolated from Nfkbid-deficient and WT
mice was comparable (Figures 4D and 4E). Taken together, we
found no evidence that IkBNS affects phenotype or function of
mature Treg cells.
IkBNS Is Expressed by Treg Precursor Cells and Controls
Their Transition into Mature Treg Cells
A previous study reported that IkBNS is directly repressed by
Foxp3 (Marson et al., 2007). Also, IkBNS expression was not
inducible via CD3/CD28/IL-2 stimulation in purified Treg cells
in contrast to conventional T cells (Figure 4F) (Touma et al.,
2007). Because IkBNS is suppressed in mature Treg cells, but. IFN-g and IL-6 release in colon cultures of Rag1-deficient mice injected with
e mean; error bars represent SEM. Numbers indicate the percentages of CD4+
), and (E), each symbol indicates an individual mouse. Horizontal lines represent
-tailed Mann-Whitney tests; a < 0.05. n.s., not significant.
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Figure 5. IkBNS Controls Transition of Immature Treg Precursor Cells into Mature Regulatory T Cells
(A) Expression of IkBNS (left panel) and c-Rel (right panel) in stages of nTreg cell development, analyzed by qPCR (n = 4).
(B) Representative dot-plots of CD25+GITR+ T cells pregated on the CD4+CD8Foxp3 compartment in WT (Nfkbid+/+), heterozygous (Nfkbid-/+), and IkBNS-
deficient (Nfkbid/) mice are shown. Numbers indicate the frequencies of gated Treg precursor cells.
(C) Statistical summary of the percentages of CD25+GITR+CD4+CD8Foxp3 Treg precursor cells in the thymi of Nfkbid+/+ (n = 8), Nfkbid/+ (n = 10), and
Nfkbid/ (n = 10) mice is shown.
(D) Percentages of Foxp3 Treg precursor cells and Foxp3+ mature Treg cells within the thymic CD8CD4+CD25+GITR+ compartment were determined by flow
cytometry. Representative dot-plots of cells from Nfkbid+/+, Nfkbid/+, and Nfkbid/ mice are shown. Lower numbers indicate percentages of CD4+Foxp3
precursor cells, upper numbers indicate percentages of CD4+Foxp3+ Treg cells.
(E) Summary of percentages of Treg precursor cells (right panel) and mature Treg cells (left panel) within the thymic CD8CD4+CD25+GITR+ subset in Nfkbid+/+
(n = 7), Nfkbid/+ (n = 9), and Nfkbid/ (n = 9) mice is shown.
(F) Purified Treg precursor cells from Nfkbid/Foxp3DTR-eGFP or Nfkbid+/+Foxp3DTR-eGFP mice were stimulated with 100 ng/ml murine IL-2 or left untreated for
48 hr. Conversion of Treg precursor cells into mature Treg cells was determined by measuring GFP+ cells. Representative zebra-plots and histograms of IL-2-
treated and untreated precursors fromNfkbid/Foxp3DTR-eGFP compared toNfkbid+/+Foxp3DTR-eGFP mice are shown. Numbers indicate percentages generated
GFP expressing Treg cells.
(G) Statistical summary of the conversion of Nfkbid/Foxp3DTR-eGFP and Nfkbid+/+Foxp3DTR-eGFP Treg precursor cells into mature Treg cells after IL-2 treatment
as in (F). For (C), (E), and (G), each symbol indicates an individual mouse. Horizontal lines represent the mean. For (A), (C), (E), and (G), error bars indicate the SEM.
Statistical analyses were performed by two-tailed Mann-Whitney tests; a < 0.05; n.s., not significant.
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IkBNS Regulates Foxp3 Inductionmixed bone-marrow chimeric mice demonstrated that IkBNS
intrinsically regulates Treg cell development (Figures 1D
and 1E), we speculated that IkBNS is expressed during thymic
Treg cell maturation. To this end, we purified thymocytes
according to the developmental sequence of the two-step
model (Figure S5A). Strikingly, IkBNS was strongly expressed
in CD4+CD25+GITR+Foxp3 nTreg precursor cells and declined
upon Foxp3 induction (Figure 5A). In contrast, c-Rel expression
was maintained after transition of nTreg precursor cells into
Foxp3+ Treg cells (Figure 5A). Of note, Card11-deficient and
Rel-deficient mice display a reduction of precursors con-
tributing to the overall Treg cell reduction in these mice (Grigor-
iadis et al., 2011; Molinero et al., 2009). However, we found
a significant increase in the frequencies of nTreg precursor1004 Immunity 37, 998–1008, December 14, 2012 ª2012 Elsevier Inccells in thymi of Nfkbid-deficient mice (Figures 5B and 5C), indi-
cating impaired transition of precursor cells into Foxp3+ Treg
cells.
To explain this phenomenon, the distribution of Treg precursor
cells and mature Treg cells within the CD8CD4+CD25+GITR+
population was analyzed. Foxp3 Treg precursor cells made
up the majority of this compartment in the thymi of Nfkbid-
deficient mice, in contrast to heterozygous and WT littermates
(Figures 5D and 5E). According to the two-step model, Foxp3
induction in precursor cells is induced by IL-2 (Lio and Hsieh,
2008). To determine whether IkBNS deficiency indeed re-
gulates transition of precursors into mature Treg cells,
Nfkbid/Foxp3DTR-eGFP and Nfkbid+/+Foxp3DTR-eGFP reporter
mice were used for IL-2-induced transition in vitro. Of note,.
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tected in Nfkbid/Foxp3DTR-eGFP mice as in nonreporter mice
excluding influences by the BAC transgene (Figure S5B). Upon
IL-2 treatment of isolated CD8CD4+GITR+CD25+GFP, Treg
precursor cells less than 25% of Nfkbid-deficient in contrast to
about 40% of Nfkbid+/+ precursor cells cells developed into
mature Foxp3+ Treg cells (Figures 5F and 5G). Despite a mild
difference in CD122 expression, steady-state phosphorylation
of STAT5 in Treg precursor cells from WT and Nfkbid-deficient
mice was similar, (Figure S5C), indicating normal IL-2 signal
transduction in Nfkbid-deficient T cells.
IkBNS Interacts with p50 and c-Rel and Binds
to the Foxp3 Promoter and CNS3
To investigate how IkBNS controls Treg cell development, we
asked whether it binds directly to the Foxp3 locus. Because
numbers of Treg precursor cells were too low to allow for
biochemical analyses, Nfkbid induction was analyzed in
thymic CD4+GITRCD25Foxp3 cells, which give rise to Treg
precursor cells, and peripheral CD4+CD25 cells. Nfkbid was
induced by TCR triggering in thymic and peripheral CD4+
T cells, but not by CD28 or IL-2 costimulation alone (Figure 6A).
Thus, the latter cell type was chosen to study the interaction of
IkBNS with known NFkB components and the Foxp3 locus. Frac-
tionized cell lysis of PMA/ionomycin stimulated CD4+CD25
T cells revealed nuclear translocation of p50, p65, and c-Rel (Fig-
ure 6B). IkBNS appeared within the first 4 hr of stimulation as
a 35 kDa IkBNS protein in the cytoplasm and as two 70 kDa IkBNS
isoforms in the nucleus, i.e., with similar kinetics as c-Rel (Fig-
ure 6B). Although the 70 kDa isoforms cannot be deduced
from the Nfkbid gene structure and have not been reported
before, their absence in Nfkbid-deficient cells indicates that
these isoforms are Nfkbid gene products (data not shown).
Because IkBNS does not contain a DNA-binding motif, the
protein requires interaction with NFkB subunits to associate
with DNA. Coimmunoprecipitations (coIP) using cytoplasmic
and nuclear extracts of stimulated CD4+CD25 T cells revealed
that cytoplasmic 35 kDa IkBNS did not interact with any NFkB
subunit (Figure 6C). Strong coprecipitation of IkBNS with p50
and to a weaker extent with c-Rel was found in nuclear extracts,
but interaction with p65 was not observed (Figure 6C).
NFkB binding to the promoter, CNS2, and CNS3 of the Foxp3
gene has been previously described (Figure S6A) (Long et al.,
2009; Ruan et al., 2009; Zheng et al., 2010). We found by native
chromatin immunoprecipitations (ChIP) binding of IkBNS to the
Foxp3 promoter and CNS3 (Figures 6D and 6E). Furthermore,
pull-down analyses revealed binding of IkBNS, c-Rel, and p50
to the single kB site of CNS3 (Figure 6F). Two DNA sequences
of the IL-2 promoter, a classical kB-binding site and a CD28-
responsive element known to bind p50 and c-Rel, respectively,
served as controls (Touma et al., 2007). The consequence of
IkBNS deficiency for the transcriptional activity was addressed
in T cells isolated from WT and Nfkbid-deficient mice using
a luciferase-based reporter gene assay, as previously reported
(Polansky et al., 2010; Zheng et al., 2010). Of note, the Foxp3
promoter alone has only minimal transcriptional activity (Zheng
et al., 2010). Using a construct, in which the promoter is fused
to CNS3, transcription is not enhanced (Figure 6G), because
the pioneer element functions as a chromatin opener of theImmFoxp3 locus (Zheng et al., 2010). However, when the promoter
was fused to the CNS2 enhancer segment, strong luciferase
activity was observed (Zheng et al., 2010), which was reduced
by about 50% in Nfkbid-deficient T cells (Figure 6G), further
emphasizing that IkBNS directly regulates Foxp3 induction.
DISCUSSION
Recent studies revealed the importanceofNFkBsignaling for Treg
cell generation, but the participating proteins remain largely
unknown (Lu and Rudensky, 2009). This study shows that the
atypical IkB protein IkBNS regulates Foxp3 expression, leading
to a reduction of mature Treg cells in Nfkbid-deficient mice by
about 50%. Furthermore, we demonstrated IkBNS expression
during thymic nTreg cell development and upon TGF-b treatment
of naive cells. Consequently, Nfkbid-deficient T cells showed
reduced induction of Foxp3 when stimulated with low doses of
TGF-b. Moreover, fewer Foxp3 expressing cells developed from
adoptively transferred Nfkbid-deficient conventional cells.
Frequencies of IFN-g-producing effector T cells and total CD4
cells were normal. Thus, it is conceivable that impaired Treg cell
generation caused the observed exacerbated colitis in recipients
of Nfkbid-deficient cells, although we cannot completely exclude
that altered Th1 cell activity contributes to this phenotype.
Because expression of Treg cell signature proteins, TSDRmethyl-
ation, and suppressive activity of Treg cells from Nfkbid-deficient
and WT mice were comparable, IkBNS seems dispensable for
maintenance of mature Treg cells. This is supported by the fact
that Nfkbid itself is suppressed in mature Treg cells (Marson
etal., 2007). Interestingly,Nfkbid-deficient Tregcells displaymildly
stronger proliferation compared to WT cells as assessed by Ki67
and BrdU staining. Although apoptosis is not increased in
Nfkbid-deficient Treg cells, their absolute number is reduced.
Most likely, mature Nfkbid-deficient Treg cells try to compensate
their reduced generation by undergoing enhanced homeostatic
proliferation. However, because the starting population is
massively reduced, this is insufficient to restore normal Treg cell
numbers before they undergo apoptosis.
Previous work concluded that Carma1 is necessary for the
generation of Treg precursor cells, which are almost completely
abolished inCard11-deficient mice (Barnes et al., 2009;Molinero
et al., 2009). Similarly, Rel-deficient mice display less Treg
precursor cells (Grigoriadis et al., 2011). We present evidence
that IkBNS, which is strongly expressed in Treg precursor cells,
triggers the transition of precursor cells into Foxp3+ Treg cells
but is dispensable for precursor development. As further devel-
opment is delayed, IkBNS deficiency causes an increase in
precursor cells. NFkB binds to the Foxp3 locus in Foxp3
conventional cells upon TCR triggering, even without a Foxp3
inducing stimulus (Long et al., 2009; Ruan et al., 2009). Accord-
ingly, current models suggest NFkB to be a pioneer transcription
factor activated upon initial TCR stimulation. Thus, in addition to
the direct control of Foxp3 expression, NFkB renders the locus
responsive for secondary transcription factors activated, e.g.,
by gc cytokines (Hori, 2010; Hsieh, 2009). An obvious conse-
quence of this model is reduced responsiveness of Treg
precursor cells to gc cytokines, when the instructive NFkB signal
is impaired. In line with this prediction, we demonstrated that
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Figure 6. IkBNS Binds to the Foxp3 Promoter and CNS3, Is Induced by CD3 Mediated Signals, and Interacts with c-Rel and p50
(A) Expression of IkBNS in thymic CD4
+CD25GITRFoxp3 cells (left panel, n = 6) and peripheral CD4+CD25 cells (right panel, n = 4) stimulated with the
indicated combinations of 10 mg/ml anti-CD3, 5 mg/ml anti-CD28, or 10 ng/ml IL-2, respectively, analyzed by qPCR.
(B) NFkB activation was analyzed by immunoblotting of cytoplasmic and nuclear extracts. CD4+CD25 Tcon cells were purified by FACS, expanded for 7 days
in vitro, and, subsequently, stimulated with 1 mM ionomycin and 10 ng/ml PMA for the indicated time periods.
(C) CD4+CD25 Tcon cells were expanded as described above and stimulated for 4 hr with PMA/ionomycin. Cytoplasmic and nuclear extracts were used for
immunoprecipitations (IP) of IkBNS, c-Rel, and p50/p105 with rabbit polyclonal antibodies. CoIP of the proteins was analyzed via immunoblotting.
(D) ChIP using an IkBNS-specific rabbit polyclonal antibody in WT and Nfkbid-deficient CD4
+CD25 Tcon cells, stimulated for the indicated times with PMA/
ionomycin. Representative PCR results of amplification of promoter, CNS2, and CNS3 are shown. Nfkbid-deficient cells served as controls.
(E) Representative qPCR analysis of chromatin IPs, corresponding to (D). Anti-Acetyl-Histone 3 antibody and input served as positive controls, unspecific rabbit
IgG as a negative control.
(F) Interaction of IkBNS with the single kB site of the CNS3/pioneer element was analyzed by DNA pull-down. Nuclear extracts were prepared from expanded and
stimulated CD4+CD25 T cells as described in (B) and (C). Eluted proteins were analyzed via immunoblot. Nuclear and cytoplasmic extracts were used as
stimulation controls. Classical NFkBbinding site and the CD28 response element of the IL-2 locus, known to bind IkBNS/p50 and c-Rel, respectively, were used as
interaction controls.
(G) Luciferase-based reported gene assay using constructs containing regulatory elements of the Foxp3 locus fused to the Foxp3 promoter. Fold induction of the
indicated constructs, nucleofected intoWT (filled bars; n = 3), and IkBNS-deficient (empty bars; n = 3) CD4
+CD25 T cells are shown. For (B), (C), (D), and (F), each
blot is representative of at least three independent experiments. For (A), (E), and (G), error bars represent SEM. Statistical analyses were performed by two-tailed
Mann-Whitney tests; a < 0.05.
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c-Rel, demonstrating that it functions in precursor generation
as well as Foxp3 induction (Grigoriadis et al., 2011). However,
in Rel-deficient precursors phosphorylation of STAT5 was
impaired (Grigoriadis et al., 2011), whereas we found no
evidence for altered phosphorylation of STAT5 in Nfkbid-
deficient precursors. Regarding the functional differences of
Carma1, c-Rel and IkBNS, it is conceivable that those proteins1006 Immunity 37, 998–1008, December 14, 2012 ª2012 Elsevier Incare sequentially activated during nTreg cell generation. The
activity of Carma1 is essential for Treg cell precursor generation
(Barnes et al., 2009), IkBNS forces transition into mature Treg
cells, and c-Rel participates in both processes (Grigoriadis
et al., 2011). Therefore, NFkB activity critically regulates both
checkpoints of the two-step model.
Binding of c-Rel to the promoter, CNS2, and CNS3 of the
Foxp3 locus has been previously reported (Figure S6A) (Long.
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IkBNS Regulates Foxp3 Inductionet al., 2009; Ruan et al., 2009; Zheng et al., 2010). We detected
binding of IkBNS to the promoter and CNS3 using ChIP. More-
over, transcriptional activity inNfkbid-deficient T cells is reduced
as assessed by reporter gene assays. Thus, binding of IkBNS to
the promoter is necessary for full transcriptional activation of the
Foxp3 locus. Via DNA pull-down experiments, we additionally
found binding of IkBNS, p50, and c-Rel to CNS3. Because this
segment is thought to be an origin of chromatin opening during
Foxp3 induction, it is likely that IkBNS participates in that
process. This idea is further supported by previous studies,
which demonstrated that atypical IkBs interact with chromatin
remodeling enzymes (Dechend et al., 1999). Because Foxp3 is
the master transcription factor for Treg cell development and
function, we conclude that regulation of Foxp3 expression is
a major mechanism of IkBNS driving Treg cell development
though we cannot formally exclude that indirect mechanisms
involving other IkBNS target genes may exist.
In summary, our data highlight the importance of the NFkB
regulator IkBNS for the development of thymic derived and
induced Treg cells. A recent study illustrated that Th17 cell
development and function depends on the BCL-3 class protein
IkBz, which shows high sequence similarity to IkBNS (Okamoto
et al., 2010). In line with our findings, the group of atypical IkBs
might be of particular importance for the development of distinct
T helper cell subsets and could represent suitable pharmacolog-
ical targets for the treatment of chronic inflammatory diseases.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 Nfkbid/ mice and Foxp3DTR-eGFP (DEREG) mice have been
described previously and were kept under pathogen-free conditions in the
animal facilities of the Heinrich-Heine University Du¨sseldorf and Helmholtz-
Centre for Infection Research (HZI), Braunschweig (Fiorini et al., 2002; Lahl
et al., 2007). Thy1.1 congenic mice were bred in the animal facility at the
HZI, Braunschweig. All animal experiments and breeding were performed in
accordance with the guidelines of national and local authorities.
Generation of Mixed Bone Marrow Chimeric Mice
Bone marrow cells were isolated from femurs and tibias of donor animals
(Nfkbid/Thy1.2+ and Nfkbid+/+Thy1.1+). C57BL/6 WT recipient mice were
coinjected with 5 3 106 cells of each type 6 hr after sublethal irradiation
(9 Gy). Eight weeks later, micewere sacrificed and analyzed by flow cytometry.
Adoptive Transfer Colitis
Freshly isolated CD4+CD25 T cells (5 3 105) from C57BL/6 and Nfkbid-
deficient mice were injected intraperitoneally into Rag1/ mice in 200 ml of
PBS. CD4+CD25 T cells were isolated from spleens and lymph nodes by
MACS separation (CD4 T Cell Isolation Kit, CD25-PE Kit, Miltenyi) to a purity
of >98% as evaluated by flow cytometry. WT and IkBNS-deficient mice were
obtained from the animal facility of the Heinrich-Heine-University, Du¨sseldorf.
Rag1/ mice were bred at the animal facility of the Charite´ Berlin. All mice
were kept under specific pathogen-free conditions and used according to
local animal care regulations. Further information can be found online in the
Supplemental Experimental Procedures.
Expansion CD4+CD25– T Cells
For IP analyses, DNA pull-downs and luciferase assays CD4+CD25 T cells
were expanded in vitro. Purified T cells (4 3 106) were resuspended in 4 ml
fully supplemented RPMI and stimulated with 1 mg/ml plate-bound anti-
CD3 (145-2C11, Biolegend) and 2 mg/ml soluble CD28 (eBioscience) in the
presence of 10 ng/ml murine IL-2 (402-ML, R&D) in a 6-well plate. On
day 3, cells were transferred in a total of 15 ml fresh RPMI without antibodiesImmand transferred into a 10 cm dish. Cells were used on day 6 for further
experiments.
Luciferase Assays
Luciferase constructs of the Foxp3 locus were a kind gift of Dr. Ye Zheng (Salk
Institute for Biological Studies, La Jolla, CA, USA). Luciferase assays were
performed as described (Polansky et al., 2010).
DNA Pull-Down
For DNA pull-down, cytoplasmic extracts of CD4+CD25 cells, stimulated for
4 hr with 10 ng/ml PMA and 1 mM ionomycin, were prepared as described
above. Nuclear extracts were prepared using HGMK buffer (0.1% NP-40,
10 mM HEPES, pH7.9, 5 mM MgCl2, 100 mM KCl, 1 mM DTT, 10% glycerol
with inhibitors), and incubated overnight with 8 mg DNA-oligo, bound to
paramagnetic streptavidin beads (MyOne Streptavidin C1, Invitrogen).
Unbound proteins were removed and eluates were analyzed by immunoblot-
ting. Sequences for DNA-oligos of CNS3, of the classical kB-site and of
the CD28-responsive element of the IL-2 promoter, were taken from Zheng
et al. (2010) and Touma et al. (2007).
Chromatin Immunoprecipitation
For ChIP analyses, WT and Nfkbid-deficient CD4+CD25 T cells were
stimulated with 10 ng/ml PMA and 1 mM ionomycin for the indicated times.
ChIP was performed using ChIP-IT Express Enzymatic kit (Active Motif).
The customer’s procedure was modified to achieve ChIP without crosslinking.
As a result, procedural steps to remove PFA and revert crosslinking were
not performed. After elution of the precipitated promoter DNA, CNS2 and
CNS3 were amplified by PCR. Primer sequences can be found online in the
Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and Supplemental Experimental
Procedures and can be found with this article online at http://dx.doi.org/
10.1016/j.immuni.2012.08.023.
ACKNOWLEDGMENTS
We thank Sabrina Schumann, Dominique Gollasch, Stephanie Grosch, and
Inka Freise for their excellent technical assistance, Ralf Ho¨cker for help with
apoptosis experiments, and AlishaWalker for critically reading themanuscript.
We are grateful to David Dettbarn and colleagues for excellent mouse
husbandry. Rag1/ mice were a kind gift from Thomas Blankenstein and
Charite´ Berlin. DNA methylation experiments were developed and performed
by Udo Baron and Sven Olek at Epiontis GmbH. We thank the Forschungs-
kommission of the Heinrich-Heine University Du¨sseldorf for initial funding.
Further support was provided by the Deutsche Forschungsgemeinschaft
(SI 749/5-3) and the SFB 738/C-6 and SFB 685/B-7.
Received: November 14, 2011
Accepted: August 21, 2012
Published: November 29, 2012
REFERENCES
Apostolou, I., Sarukhan, A., Klein, L., and von Boehmer, H. (2002). Origin
of regulatory T cells with known specificity for antigen. Nat. Immunol. 3,
756–763.
Baldwin, A.S., Jr. (1996). The NF-kappa B and I kappa B proteins: new
discoveries and insights. Annu. Rev. Immunol. 14, 649–683.
Barnes, M.J., Krebs, P., Harris, N., Eidenschenk, C., Gonzalez-Quintial, R.,
Arnold, C.N., Crozat, K., Sovath, S., Moresco, E.M., Theofilopoulos, A.N.,
et al. (2009). Commitment to the regulatory T cell lineage requires CARMA1
in the thymus but not in the periphery. PLoS Biol. 7, e51.
Bennett, C.L., Christie, J., Ramsdell, F., Brunkow, M.E., Ferguson, P.J.,
Whitesell, L., Kelly, T.E., Saulsbury, F.T., Chance, P.F., and Ochs, H.D.unity 37, 998–1008, December 14, 2012 ª2012 Elsevier Inc. 1007
Immunity
IkBNS Regulates Foxp3 Induction(2001). The immune dysregulation, polyendocrinopathy, enteropathy, X-linked
syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20–21.
Bonizzi, G., and Karin, M. (2004). The two NF-kappaB activation pathways and
their role in innate and adaptive immunity. Trends Immunol. 25, 280–288.
Brunkow, M.E., Jeffery, E.W., Hjerrild, K.A., Paeper, B., Clark, L.B., Yasayko,
S.A., Wilkinson, J.E., Galas, D., Ziegler, S.F., and Ramsdell, F. (2001).
Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal
lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27, 68–73.
Burchill, M.A., Yang, J., Vogtenhuber, C., Blazar, B.R., and Farrar, M.A. (2007).
IL-2 receptor beta-dependent STAT5 activation is required for the develop-
ment of Foxp3+ regulatory T cells. J. Immunol. 178, 280–290.
Burchill, M.A., Yang, J., Vang, K.B., Moon, J.J., Chu, H.H., Lio, C.W., Vegoe,
A.L., Hsieh, C.S., Jenkins, M.K., and Farrar, M.A. (2008). Linked T cell receptor
and cytokine signaling govern the development of the regulatory T cell reper-
toire. Immunity 28, 112–121.
Chen,W., Jin, W., Hardegen, N., Lei, K.J., Li, L., Marinos, N., McGrady, G., and
Wahl, S.M. (2003). Conversion of peripheral CD4+CD25- naive T cells to
CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor
Foxp3. J. Exp. Med. 198, 1875–1886.
Dechend, R., Hirano, F., Lehmann, K., Heissmeyer, V., Ansieau, S., Wulczyn,
F.G., Scheidereit, C., and Leutz, A. (1999). The Bcl-3 oncoprotein acts as
a bridging factor between NF-kappaB/Rel and nuclear co-regulators.
Oncogene 18, 3316–3323.
Fiorini, E., Schmitz, I., Marissen, W.E., Osborn, S.L., Touma, M., Sasada, T.,
Reche, P.A., Tibaldi, E.V., Hussey, R.E., Kruisbeek, A.M., et al. (2002).
Peptide-induced negative selection of thymocytes activates transcription of
an NF-kappa B inhibitor. Mol. Cell 9, 637–648.
Floess, S., Freyer, J., Siewert, C., Baron, U., Olek, S., Polansky, J., Schlawe,
K., Chang, H.D., Bopp, T., Schmitt, E., et al. (2007). Epigenetic control of the
foxp3 locus in regulatory T cells. PLoS Biol. 5, e38.
Ghosh, S., and Hayden, M.S. (2008). New regulators of NF-kappaB in
inflammation. Nat. Rev. Immunol. 8, 837–848.
Grigoriadis, G., Vasanthakumar, A., Banerjee, A., Grumont, R., Overall, S.,
Gleeson, P., Shannon, F., and Gerondakis, S. (2011). c-Rel controls multiple
discrete steps in the thymic development of Foxp3+ CD4 regulatory T cells.
PLoS ONE 6, e26851.
Hayden, M.S., and Ghosh, S. (2012). NF-kB, the first quarter-century:
remarkable progress and outstanding questions. Genes Dev. 26, 203–234.
Hori, S. (2010). c-Rel: a pioneer in directing regulatory T-cell lineage commit-
ment? Eur. J. Immunol. 40, 664–667.
Hori, S., Nomura, T., and Sakaguchi, S. (2003). Control of regulatory T cell
development by the transcription factor Foxp3. Science 299, 1057–1061.
Hsieh, C.S. (2009). Kickstarting Foxp3 with c-Rel. Immunity 31, 852–853.
Hsieh, C.S., Liang, Y., Tyznik, A.J., Self, S.G., Liggitt, D., and Rudensky, A.Y.
(2004). Recognition of the peripheral self by naturally arising CD25+ CD4+
T cell receptors. Immunity 21, 267–277.
Isomura, I., Palmer, S., Grumont, R.J., Bunting, K., Hoyne, G., Wilkinson, N.,
Banerjee, A., Proietto, A., Gugasyan, R., Wu, L., et al. (2009). c-Rel is required
for the development of thymic Foxp3+ CD4 regulatory T cells. J. Exp. Med.
206, 3001–3014.
Jordan, M.S., Boesteanu, A., Reed, A.J., Petrone, A.L., Holenbeck, A.E.,
Lerman, M.A., Naji, A., and Caton, A.J. (2001). Thymic selection of
CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat.
Immunol. 2, 301–306.
Kuwata, H., Matsumoto, M., Atarashi, K., Morishita, H., Hirotani, T., Koga, R.,
and Takeda, K. (2006). IkappaBNS inhibits induction of a subset of Toll-like
receptor-dependent genes and limits inflammation. Immunity 24, 41–51.
Lahl, K., Loddenkemper, C., Drouin, C., Freyer, J., Arnason, J., Eberl, G.,
Hamann, A., Wagner, H., Huehn, J., and Sparwasser, T. (2007). Selective
depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J. Exp.
Med. 204, 57–63.1008 Immunity 37, 998–1008, December 14, 2012 ª2012 Elsevier IncLio, C.W., and Hsieh, C.S. (2008). A two-step process for thymic regulatory
T cell development. Immunity 28, 100–111.
Liston, A., and Rudensky, A.Y. (2007). Thymic development and peripheral
homeostasis of regulatory T cells. Curr. Opin. Immunol. 19, 176–185.
Long, M., Park, S.G., Strickland, I., Hayden, M.S., and Ghosh, S. (2009).
Nuclear factor-kappaB modulates regulatory T cell development by directly
regulating expression of Foxp3 transcription factor. Immunity 31, 921–931.
Lu, L.F., and Rudensky, A. (2009). Molecular orchestration of differentiation
and function of regulatory T cells. Genes Dev. 23, 1270–1282.
Mankan, A.K., Lawless, M.W., Gray, S.G., Kelleher, D., and McManus, R.
(2009). NF-kappaB regulation: the nuclear response. J. Cell. Mol. Med. 13,
631–643.
Marie, J.C., Letterio, J.J., Gavin, M., and Rudensky, A.Y. (2005). TGF-beta1
maintains suppressor function and Foxp3 expression in CD4+CD25+ regula-
tory T cells. J. Exp. Med. 201, 1061–1067.
Marson, A., Kretschmer, K., Frampton, G.M., Jacobsen, E.S., Polansky, J.K.,
MacIsaac, K.D., Levine, S.S., Fraenkel, E., von Boehmer, H., and Young, R.A.
(2007). Foxp3 occupancy and regulation of key target genes during T-cell stim-
ulation. Nature 445, 931–935.
Molinero, L.L., Yang, J., Gajewski, T., Abraham, C., Farrar, M.A., and Alegre,
M.L. (2009). CARMA1 controls an early checkpoint in the thymic development
of FoxP3+ regulatory T cells. J. Immunol. 182, 6736–6743.
Okamoto, K., Iwai, Y., Oh-Hora, M., Yamamoto, M., Morio, T., Aoki, K., Ohya,
K., Jetten, A.M., Akira, S., Muta, T., and Takayanagi, H. (2010). IkappaBzeta
regulates T(H)17 development by cooperating with ROR nuclear receptors.
Nature 464, 1381–1385.
Perkins, N.D., and Gilmore, T.D. (2006). Good cop, bad cop: the different faces
of NF-kappaB. Cell Death Differ. 13, 759–772.
Polansky, J.K., Kretschmer, K., Freyer, J., Floess, S., Garbe, A., Baron, U.,
Olek, S., Hamann, A., vonBoehmer, H., and Huehn, J. (2008). DNAmethylation
controls Foxp3 gene expression. Eur. J. Immunol. 38, 1654–1663.
Polansky, J.K., Schreiber, L., Thelemann, C., Ludwig, L., Kru¨ger, M.,
Baumgrass, R., Cording, S., Floess, S., Hamann, A., and Huehn, J. (2010).
Methylation matters: binding of Ets-1 to the demethylated Foxp3 gene contrib-
utes to the stabilization of Foxp3 expression in regulatory T cells. J. Mol. Med.
88, 1029–1040.
Ruan, Q., Kameswaran, V., Tone, Y., Li, L., Liou, H.C., Greene, M.I., Tone, M.,
and Chen, Y.H. (2009). Development of Foxp3(+) regulatory t cells is driven by
the c-Rel enhanceosome. Immunity 31, 932–940.
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and Toda, M. (1995).
Immunologic self-tolerance maintained by activated T cells expressing IL-2
receptor alpha-chains (CD25). Breakdown of a single mechanism of self-
tolerance causes various autoimmune diseases. J. Immunol. 155, 1151–1164.
Sakaguchi, S., Wing, K., and Miyara, M. (2007). Regulatory T cells - a brief
history and perspective. Eur. J. Immunol. 37 (Suppl 1 ), S116–S123.
Thome, M. (2004). CARMA1, BCL-10 and MALT1 in lymphocyte development
and activation. Nat. Rev. Immunol. 4, 348–359.
Touma, M., Antonini, V., Kumar, M., Osborn, S.L., Bobenchik, A.M., Keskin,
D.B., Connolly, J.E., Grusby, M.J., Reinherz, E.L., and Clayton, L.K. (2007).
Functional role for I kappa BNS in T cell cytokine regulation as revealed by
targeted gene disruption. J. Immunol. 179, 1681–1692.
Vang, K.B., Yang, J., Mahmud, S.A., Burchill, M.A., Vegoe, A.L., and Farrar,
M.A. (2008). IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redun-
dantly govern CD4+Foxp3+ regulatory T cell development. J. Immunol. 181,
3285–3290.
Weil, R., and Israe¨l, A. (2006). Deciphering the pathway from the TCR to
NF-kappaB. Cell Death Differ. 13, 826–833.
Zheng, Y., Josefowicz, S., Chaudhry, A., Peng, X.P., Forbush, K., and
Rudensky, A.Y. (2010). Role of conserved non-coding DNA elements in the
Foxp3 gene in regulatory T-cell fate. Nature 463, 808–812..
